TSE:VRX

Valeant Pharmaceuticals International Competitors

Add
Compare
Today's Range N/A
50-Day Range
C$30.80
MA: C$30.80
C$30.80
52-Week Range N/A
Volume1.23 million shs
Average Volume1.38 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Valeant Pharmaceuticals International (TSE:VRX) Vs. THCX, GLH, ACG, HC, BIO, and BBM

Should you be buying VRX stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Valeant Pharmaceuticals International, including (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Bio-Rad Laboratories (BIO), and Blueberries Medical (BBM).

(THCX.V) (CVE:THCX) and Valeant Pharmaceuticals International (TSE:VRX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

Profitability

This table compares (THCX.V) and Valeant Pharmaceuticals International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
Valeant Pharmaceuticals InternationalN/AN/AN/A

Valuation and Earnings

This table compares (THCX.V) and Valeant Pharmaceuticals International's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
Valeant Pharmaceuticals InternationalN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for (THCX.V) and Valeant Pharmaceuticals International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
Valeant Pharmaceuticals International0000N/A

31444 (CNSX:GLH) and Valeant Pharmaceuticals International (TSE:VRX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations and price targets for 31444 and Valeant Pharmaceuticals International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
314440000N/A
Valeant Pharmaceuticals International0000N/A

Profitability

This table compares 31444 and Valeant Pharmaceuticals International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
31444N/AN/AN/A
Valeant Pharmaceuticals InternationalN/AN/AN/A

Valuation and Earnings

This table compares 31444 and Valeant Pharmaceuticals International's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
31444N/AN/AN/AN/AN/A
Valeant Pharmaceuticals InternationalN/AN/AN/AN/AN/A

Valeant Pharmaceuticals International (TSE:VRX) and 438280 (CNSX:ACG) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Analyst Ratings

This is a summary of recent ratings and target prices for Valeant Pharmaceuticals International and 438280, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Valeant Pharmaceuticals International0000N/A
4382800000N/A

Profitability

This table compares Valeant Pharmaceuticals International and 438280's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Valeant Pharmaceuticals InternationalN/AN/AN/A
438280N/AN/AN/A

Valuation & Earnings

This table compares Valeant Pharmaceuticals International and 438280's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Valeant Pharmaceuticals InternationalN/AN/AN/AN/AN/A
438280N/AN/AN/AN/AN/A

Valeant Pharmaceuticals International (TSE:VRX) and 815446 (CNSX:HC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Analyst Ratings

This is a summary of recent ratings and target prices for Valeant Pharmaceuticals International and 815446, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Valeant Pharmaceuticals International0000N/A
8154460000N/A

Valuation & Earnings

This table compares Valeant Pharmaceuticals International and 815446's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Valeant Pharmaceuticals InternationalN/AN/AN/AN/AN/A
815446N/AN/AN/AN/AN/A

Profitability

This table compares Valeant Pharmaceuticals International and 815446's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Valeant Pharmaceuticals InternationalN/AN/AN/A
815446N/AN/AN/A

Valeant Pharmaceuticals International (TSE:VRX) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent ratings and target prices for Valeant Pharmaceuticals International and Bio-Rad Laboratories, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Valeant Pharmaceuticals International0000N/A
Bio-Rad Laboratories0000N/A

Valuation & Earnings

This table compares Valeant Pharmaceuticals International and Bio-Rad Laboratories' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Valeant Pharmaceuticals InternationalN/AN/AN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A

Profitability

This table compares Valeant Pharmaceuticals International and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Valeant Pharmaceuticals InternationalN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/A

Blueberries Medical (CNSX:BBM) and Valeant Pharmaceuticals International (TSE:VRX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, institutional ownership, valuation, earnings and analyst recommendations.

Analyst Ratings

This is a breakdown of current recommendations for Blueberries Medical and Valeant Pharmaceuticals International, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Blueberries Medical0000N/A
Valeant Pharmaceuticals International0000N/A

Valuation & Earnings

This table compares Blueberries Medical and Valeant Pharmaceuticals International's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Blueberries MedicalN/AN/AN/AN/AN/A
Valeant Pharmaceuticals InternationalN/AN/AN/AN/AN/A

Profitability

This table compares Blueberries Medical and Valeant Pharmaceuticals International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Blueberries MedicalN/AN/AN/A
Valeant Pharmaceuticals InternationalN/AN/AN/A


Valeant Pharmaceuticals International Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00Gap Down
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.